ÂÜÀòÂÒÂ×

Jonathan Cabral is a seasoned professional in the pharmaceutical and healthcare industries, currently serving as the US Head of Patient Services and Market Access at NS Pharma, Inc., where a key achievement includes the successful launch of Viltepso during the Covid-19 pandemic. With extensive experience in healthcare consulting, sales, and marketing, Cabral has held significant roles at various companies, including Vice President positions at Gaumard Scientific, Besins Pharmaceuticals, Innurvation, Inc., and BioniCare Medical Technologies, Inc. Educational qualifications include an MBA in Marketing/Finance from Boston University's Questrom School of Business and a BA in Economics from Middlebury College. Cabral has a strong background in commercial strategy, market access, and patient services, particularly in the rare disease orphan drug sector.